Basilea Pharmaceutica Aktie
47,50
EUR
+0,25
EUR
+0,53
%
44,45
CHF
+0,55
CHF
+1,25
%
Werbung
Basilea Pharmaceutica Aktie Analyse
| 10.12.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 16.08.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 12.06.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 12.03.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 09.02.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 05.01.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 07.10.11 | Basilea Pharmaceutica buy | Citigroup Corp. | |
| 20.06.11 | Basilea Pharmaceutica buy | Citigroup Corp. | |
|
Werbung
|
|||
| 27.08.10 | Basilea Pharmaceutica buy | Vontobel Research | |
| 09.04.09 | Basilea Pharmaceutica | Fuchsbriefe | |
| 06.11.08 | Basilea Pharmaceutica | Focus Money | |
| 22.03.07 | Basilea Pharmaceutica | Der Aktionär | |
| 13.03.07 | Basilea Pharmaceutica | Biotech-Report | |
| 03.02.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
| 13.01.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
Werbung
Werbung